Results 51 to 60 of about 5,953 (226)
Perspectives in Clinical Research, 2021 Context: The Indian government is dispensing newer direct-acting antiviral (DAA) drugs, which may have impact on hepatitis C virus (HCV) patients’ quality of life (QoL).
Bhavya H Vyas +4 more
doaj +1 more source
Era of direct acting anti-viral agents for the treatment of hepatitis C. [PDF]
, 2018 Hepatitis C infection is universal and the most common indication of liver transplantation in the United States. The period of less effective interferon therapy with intolerable side effects has gone.
Ahmed, Monjur
core +1 more source
Treatment as Prevention for Hepatitis C (TraP Hep C) - a nationwide elimination programme in Iceland using direct-acting antiviral agents [PDF]
, 2018 To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked FilesA nationwide programme for the treatment of all patients infected with hepatitis
Bergmann, O. M. +14 more
core +1 more source
Hepatology Research, EarlyView.The post‐to pretreatment serum CXCL10 ratio was independently associated with short‐term liver function outcome following HCV eradication in cirrhotic patients. ABSTRACT Aim The prognostic value of serum C‐X‐C motif chemokine ligand 10 (CXCL10) levels for liver function was investigated in hepatitis C virus (HCV)–infected patients with compensated or ...
Takanori Suzuki +20 more
wiley +1 more source
Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1-6 receiving opioid substitution therapy [PDF]
, 2019 Background: International guidelines recommend treatment of hepatitis C virus (HCV) infection in people who inject drugs (PWID), including those on opioid substitution therapy (OST).
Alami, Negar N. +11 more
core +2 more sources
Medical Journal of Australia, Volume 222, Issue 8, Page 396-402, May 2025.Abstract Objectives To estimate and compare the costs and benefits of introducing a prison needle and syringe program in all Australian prisons. Study design Stochastic compartmental modelling study. Setting All Australian prisons, 1 January 2010 to 31 December 2030.
Farah Houdroge +6 more
wiley +1 more source
Drug–Drug Interactions of Newly Approved Direct-Acting Antiviral Agents in Patients with Hepatitis C
International Journal of General Medicine, 2021 Lu-Hua Gao, Qing-He Nie, Xi-Tai Zhao Center of Infectious Diseases, Second Affiliated Hospital, Air-Force Military Medical University, Xi’an 710038, People’s Republic of ChinaCorrespondence: Qing-He NieCenter of Infectious Diseases, Second ...
Gao LH, Nie QH, Zhao XT
doaj
Chronic hepatitis in horses with persistent equine hepacivirus infection
Equine Veterinary Journal, Volume 58, Issue 2, Page 444-457, March 2026.Abstract Background Equine hepacivirus (EqHV) is closely related to hepatitis C virus (HCV), which causes persistent infection and chronic hepatitis in people. Information on persistent EqHV infection and hepatitis is limited. Objectives To report 19 cases of chronic hepatitis and persistent EqHV infection.
Mason C. Jager +13 more
wiley +1 more source
Frontiers in MicrobiologyIntroductionData on the management of patients aged more than 85 years with chronic hepatitis C virus (HCV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequential infections are lacking.MethodsThe current study described the ...
Qing-Lei Zeng +3 more
doaj +1 more source
Sofosbuvir-velpatasvir in Mexican patients with hepatitis C: A retrospective review
Revista de Gastroenterología de México (English Edition), 2022 Introduction: The sofosbuvir-velpatasvir (SOF/VEL) combination is a direct-acting antiviral therapy that is authorized and available in Mexico, making the performance of a real-world multicenter study that evaluates the sustained virologic response at 12
J.L. Pérez-Hernández +16 more
doaj +1 more source